DOH: Clinical Advisory on Paxlovid Treatment for COVID-19 Positive and Symptomatic Patients Currently on Clozapine

Please see attached clinical advisory on Paxlovid Treatment for COVID-19 Positive and Symptomatic Patients Currently on Clozapine from NYS Office of Mental Health for considerations prior to initiating COVID-19 anti-viral treatment in patients on clozapine.

For questions, please send an e-mail to olov@omh.ny.gov.

NYSHFA/NYSCAL CONTACTS:

Lisa Volk, RN, B.P.S., LNHA
Director, Clinical & Quality Services
518-462-4800 x15